Contribution of anemia and hypertension to left ventricular hypertrophy during the initial 2 years after renal transplantation

Transplantation Proceedings

Volumn 43, Issue 6, 2011, Pages 2199-2204

  Ibernon, M ^a   Moreso, F ^b   Ruiz Majoral, A ^c   Sarrias, X ^c   Sarrias, M ^b   Grinyo J M ^c   Seron D ^b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANEMIC AGENT; ANTIHYPERTENSIVE AGENT; BELATACEPT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN STIMULATING AGENT; EVEROLIMUS; HEMOGLOBIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; AGE; AGED; ANEMIA; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; DELAYED GRAFT FUNCTION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; STEROID THERAPY; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROTEINURIA; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80051696613     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.05.006     Document Type: Article

References (23)

1. D. Levy, R. Garrison, and D. Savage Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1990 1561
2. R. Foley, H. Parfrey, and J. Harnett Clinical and echocardiographic disease in end-stage renal disease: prevalence, associations and risk factors Kidney Int 47 1995 186
3. A. Ojo Cardiovascular complications after renal transplantation and their prevention Transplantation 82 2006 603
4. C. Rigatto, and P. Parfrey Therapy Insight: management of cardiovascular disease in the renal transplant recipient Nat Clin Pract Nephrol 2 2006 514
5. A.A. Haydar, A. Covic, and S. Jayawardene Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients Transplantation 77 2004 849
6. E. Paoletti, M. Gherzi, and M. Amidone Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring Transplantation 87 2009 1864
7. A.E. Stenehjem, H. Gudmundsdottir, and I. Os Office blood pressure measurements overestimate blood pressure control in renal transplant patients Blood Press Monit 11 2006 125
8. F.A. McAlister, and S.E. Strauss Measurement of blood pressure: an evidence based review BMJ 322 2001 908
9. P. Verdecchia, F. Angeli, and R. Gattobigio Clinical usefulness of ambulatory blood pressure monitoring J Am Soc Nephrol 15 2004 S30
10. P. Verdecchia Prognostic value of ambulatory blood pressure: current evidence and clinical implications Hypertension 35 2000 844
11. G. Lipkin, B. Tucker, and M. Giles Ambulatory blood pressure and left ventricular mass in cyclosporin and non-cyclosporin treated renal transplant recipients J Hypertens 11 1993 439
12. A. Alonso Hernández, B. Bayés, and V. Cabello Tratamiento de la hipertensión arterial postrasplante renal Nefrología 29 Suppl 3 2009 16
13. R. Devereux, and N. Reichek Echocardiographic determination of left ventricular mass in man: anatomic validation of the method Circulation 55 1977 613
14. C. Rigatto, R. Foley, and G. Kent Long-term changes in left ventricular hypertrophy after renal transplantation Transplantation 4 2000 570
15. J.J. De Lima, M.L. Vieira, and L.F. Viviani Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients Nephrol Dial Transplant 17 2002 645
16. E. McGregor, G. Stewart, and R. Stuart Early echocardiographic changes and survival following renal transplantation Nephrol Dial Transplant 15 2000 93
17. M.G. Amin, H. Tighiouart, and D.E. Weiner Hematocrit and left ventricular mass The Framingham Heart Study J Am Coll Cardiol 43 2004 1276
18. R.N. Foley, P.S. Parfrey, and J.D. Harnett Clinical and echocardiographic disease in end-stage renal disease: prevalence, associations and risk factors Kidney Int 47 1995 186
19. J. Hting, W. Kramer, and G. Schtterle Analysis of left ventricular changes associated with chronic hemodialysis: a non-invasive follow-up study Nephron 49 1988 284
20. A. Covic, L. Segall, and D. Goldsmith Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients? Transplantation 11 2003 1640
21. E.P. McQuarrie, R.K. Patel, and P.B. Mark Association between proteinuria and left ventricular mass index: a cardiac MRI study in patients with chronic kidney disease Nephrol Dial Transplant 26 2011 933
22. D. Hernández, J. Lacalzada, and E. Salido Regression of left ventricular hypertrophy by lisinopril after renal transplantation: Role of ACE gene polymorphism Kidney Int 58 2000 889
23. C. Rigatto, P. Parfrey, and R. Foley Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease J Am Soc Nephrol 13 2002 1084